How reducing body temperature could help a tenth of all ICU patients
A new study reveals how lower temperatures improve the activity of surfactant, a molecular mixture that is essential for breathing. This indicates that therapeutic hypothermia is a potential treatment for acute respiratory distress syndrome, which affects
2021-02-23
(Press-News.org) ROCKVILLE, MD - A tenth of all intensive care unit patients worldwide, and many critical patients with COVID-19, have acute respiratory distress syndrome (ARDS). Therapeutic hypothermia, an intentional cooling of the body, has been suggested as a way to improve ARDS. New research by Chiara Autilio and colleagues in the lab of Jesus Perez-Gil at the Complutense University of Madrid shows not only how therapeutic hypothermia works in the lungs at the molecular level, but also why it could be successfully applied to ARDS. Autilio and her colleagues' work was published in Nature Scientific Reports in January 2021 and will be presented on Tuesday, February 23 at the 65th Annual Meeting of the Biophysical Society to be held virtually.
Inside our lungs, surfactant is a molecular mixture that is essential for breathing. Premature babies are sometimes born without yet having developed surfactant and require emergency surfactant replacement treatments in order to breathe. But surfactant is also inactivated and broken up in adults with lung injuries or inflammation.
Because therapeutic hypothermia, a cooling of the body to about 33°C (or 91°F), has been used to improve breathing for some premature babies and for some kinds of cardiac arrest in adults, and some early studies have shown a benefit for ARDS, Autilio and colleagues wanted to know if cooling could impact surfactant. They looked at the physics of isolated surfactant in their lab, and Autilio said, "unexpectedly, we found an improvement in surfactant activity at 33°C."
The team found that at 33°C, the surfactant had lower surface tension, which could make it easier for oxygen to enter the lungs. They also found that the lower tension changed the activity of the molecules in the surfactant, which prevented surfactant from being disrupted by blood molecules, which can occur during lung injury. Their results indicate that "using therapeutic hypothermia could help people with acute respiratory distress syndrome to breathe."
There are currently clinical trials underway in other labs, testing therapeutic hypothermia as a treatment for severe breathing problems associated with COVID-19, according to Autilio. And in the Perez-Gil lab at the Complutense University, "we are working to create a surfactant for adults, a surfactant that could work in the context of acute respiratory distress syndrome," says Autilio.
INFORMATION:
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-23
ROCKVILLE, MD - The remarkable genetic scissors called CRISPR/Cas9, the discovery that won the 2020 Nobel Prize in Chemistry, sometimes cut in places that they are not designed to target. Though CRISPR has completely changed the pace of basic research by allowing scientists to quickly edit genetic sequences, it works so fast that it is hard for scientists to see what sometimes goes wrong and figure out how to improve it. Julene Madariaga Marcos, a Humboldt postdoctoral fellow, and colleagues in the lab of Professor Ralf Seidel at Leipzig University in Germany, found a way to analyze the ultra-fast movements of CRISPR enzymes, which will help researchers understand how they recognize their target sequences in hopes of improving the specificity. Madariaga Marcos will present ...
2021-02-23
New compound targets neurons that initiate voluntary movement
After 60 days of treatment, diseased brain cells look like healthy cells
More research needed before clinical trial can be initiated
CHICAGO and EVANSTON--- Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
In addition to ALS, upper motor neuron degeneration also results in other motor neuron diseases, such as hereditary spastic paraplegia (HSP) and primary lateral sclerosis (PLS).
In ALS, movement-initiating nerve cells in the brain (upper motor neurons) and muscle-controlling ...
2021-02-23
According to a 2017 UCLA study, students with ADHD make up about 6% of the college student population and represent the most common type of disability supported by college disability offices. But are these students receiving enough academic support from their institutions? Despite ADHD being prevalent among college students, there has been little research focused on how having ADHD impacts the transition to college and ongoing academic success. Until now.
New research from George DuPaul, professor of school psychology and associate dean for research in Lehigh University's College of Education, and colleagues confirms students with ADHD face consequential challenges in succeeding and completing ...
2021-02-23
DURHAM, N.C. -- Younger, smaller trees that comprise much of North America's eastern forests have increased their seed production under climate change, but older, larger trees that dominate forests in much of the West have been less responsive, a new Duke University-led study finds.
Declines in these trees' seed production, or fecundity, could limit western forests' ability to regenerate following the large-scale diebacks linked to rising temperatures and intensifying droughts that are now occurring in many states and provinces.
This continental divide, reported for the ...
2021-02-23
In recent years, researchers have discovered ways to remove specific fears from the brain, increase one's own confidence, or even change people's preferences, by using a combination of artificial intelligence and brain scanning technology. Their technique could lead to new treatments for patients with conditions such as post-traumatic stress disorder (PTSD), phobias or anxiety disorders.
But while this technique is extremely promising, in some individuals it remains unsuccessful. Why are there such differences in outcome? Better understanding how the brain can self-regulate its own activity patterns would go a long way toward establishing the technique for clinical use. The researchers who spearheaded this technique have thus released a unique dataset ...
2021-02-23
Peer review/Experimental study/Animals
Propranolol, a drug that is efficacious against infantile haemangiomas ("strawberry naevi", resembling birthmarks), can also be used to treat cerebral cavernous malformations, a condition characterised by misshapen blood vessels in the brain and elsewhere. This has been shown by researchers at Uppsala University in a new study published in the scientific journal Stroke.
"Up to now, there's been no drug treatment for these patients, so our results may become hugely important for them," says Peetra Magnusson of the University's Department of Immunology, Genetics and Pathology, who headed the study.
Cerebral cavernous malformations (CCMs, also called cavernous angiomas or cavernomas) are vascular lesions ...
2021-02-23
DALLAS, Feb. 23, 2021 — Women face many female-specific risks for heart disease and stroke, including pregnancy, physical and emotional stress, sleep patterns and many physiological factors, according to multiple studies highlighted in this year’s Go Red for Women® special issue of the Journal of the American Heart Association, published online today.
“Although cardiovascular disease is the leading cause of death in men and women, women are less likely to be diagnosed and receive preventive care and aggressive treatment compared to men,” said Journal of the American Heart Association Editor-in-Chief Barry London, M.D., Ph.D., Ph.D., the Potter Lambert Chair in Internal Medicine, director of the division ...
2021-02-23
Using an innovative computational approach to analyze vast brain cell gene expression datasets, researchers at MIT and Sorbonne Université have found that Huntington's disease may progress to advanced stages more because of a degradation of the cells' health maintenance systems than because of increased damage from the disease pathology itself.
The analysis yielded a trove of specific gene networks governing molecular pathways that disease researchers may now be able to target to better sustain brain cell health amid the devastating neurodegenerative ...
2021-02-23
The use of the polymeric flame retardant PolyFR in "eco-friendly" foam plastic building insulation may be harmful to human health and the environment, according to a new commentary in Environmental Science & Technology. The authors' analysis identifies several points during the lifecycle of foam insulation that may expose workers, communities, and ecosystems to PolyFR and its potentially toxic breakdown products.
With the climate crisis fueling demand for energy-efficient insulation, the production of PolyFR is increasing rapidly. That's because this flame retardant is added to all foam plastic building insulation in North America to comply with flammability codes, replacing the flame retardant ...
2021-02-23
HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study were published in the journal Frontiers in Immunology.
T-cell immunity is one of the key mechanisms used by the human body to fight virus infections. The staging ground for cell immunity development is the presentation of virus peptides on the surface of infected cells. This is followed by activation of T lymphocytes, which start to kill the infected cells.
The ability to successfully present virus peptides is largely determined by genetics. In human cells, human leukocyte antigen class I (HLA-I) molecules are responsible for this presentation. The set of six such molecules is unique in every ...
LAST 30 PRESS RELEASES:
[Press-News.org] How reducing body temperature could help a tenth of all ICU patients
A new study reveals how lower temperatures improve the activity of surfactant, a molecular mixture that is essential for breathing. This indicates that therapeutic hypothermia is a potential treatment for acute respiratory distress syndrome, which affects
